Related Experiment Video
Updated: Jan 10, 2026

Subcostal Specimen Removal in Completely Portal Robotic Lobectomy
Published on: April 19, 2024
Early Outcomes After Robotic- Versus Video-Assisted Thoracic Surgery for Early-Stage Lung Cancer.
Yadi Zhang1, Hang Gu2, Chenyang Guo2
1Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Multiportal robotic-assisted thoracic surgery (M-RATS) offers improved early symptom and functional outcomes for lung cancer patients compared to multiportal video-assisted thoracic surgery (M-VATS). However, these patient-reported outcome advantages may not persist post-discharge.
Area of Science:
- Thoracic Surgery
- Surgical Oncology
- Patient-Reported Outcomes
Background:
- Patient-reported outcomes (PROs) are crucial for evaluating surgical intervention effectiveness.
- Comparing multiportal robotic-assisted thoracic surgery (M-RATS) with multiportal video-assisted thoracic surgery (M-VATS) is important for early-stage lung cancer treatment.
- This study assesses early PROs and clinical outcomes between M-RATS and M-VATS for lobectomy or sublobar resection.
Purpose of the Study:
- To compare early patient-reported and clinical outcomes between M-RATS and M-VATS.
- To evaluate symptom burden and functional status post-surgery for early-stage lung cancer.
- To determine the sustainability of PRO advantages after discharge.
Main Methods:
- Longitudinal cohort study (CN-PRO-Lung 3) data utilized.
- Perioperative Symptom Assessment Scale for Lung Surgery assessed PROs.
- Generalized estimation equation models compared M-RATS and M-VATS outcomes.
Main Results:
- M-RATS group showed significantly fewer moderate-to-severe symptoms (36.8% vs. 46.5%) and functional deficits (38.5% vs. 49.2%) on postoperative days 1-4.
- No significant PRO differences observed between M-RATS and M-VATS from day 1 to 30 post-discharge.
- M-RATS associated with shorter operative time, less blood loss, more lymph nodes harvested, but higher cost.
Conclusions:
- M-RATS may offer reduced early postoperative symptom burden and improved functional status compared to M-VATS for early-stage lung cancer.
- The early PRO advantages of M-RATS may not be sustained beyond the immediate postoperative period.
- Clinical benefits like shorter operative time and less blood loss favor M-RATS, despite increased cost.
More Related Videos
05:39Author Spotlight: A Non-Intubated Video-Assisted Thoracoscopic Surgery with Multimodal Analgesia and Sevoflurane Inhalation Anesthesia
Published on: May 26, 2023
03:07Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
Published on: August 19, 2025